For example, the detection of PD-1 on NK cells has been proposed as an indirect marker of contact with PD-1 expressing tumor cells and may serve as a biomarker for response to checkpoint blockade therapy (Hasim et al., 2022). The gene discussed is PDCD1; the disease is neoplasm.